Sequential chemotherapy combining Thiotepa, Etoposide and Cyclophosphamide followed by reduced-intensity conditioning in T-cell replete HLA-haploidentical hematopoietic stem cell transplantation for the treatment of refractory hematological malignancies

被引：0
|
作者：
Dulery, R. [1 ,2 ,3 ]
Menard, A. -L. [4 ]
Giannotti, F. [1 ]
Ruggeri, A. [1 ]
Brissot, E. [1 ,2 ,3 ]
Battipaglia, G. [1 ]
Belhocine, R. [1 ]
Eder, S. [1 ]
Isnard, F. [1 ]
Le Bourgeois, A. [1 ]
Rosu, A. M. [1 ]
Santoro, N. [1 ]
Mamez, A. -C. [1 ]
Lapusan, S. [1 ]
Vekhoff, A. [1 ]
Legrand, O. [1 ,2 ]
Rubio, M. -T. [1 ]
Mohty, M. [1 ,2 ,3 ]
机构：
[1] St Antoine Hosp, AP HP, Dept Hematol & Cellular Therapy, Paris, France
[2] Univ Paris 06, Paris, France
[3] INSERM, UMRs 938, Paris, France
[4] Ctr Henri Becquerel, Dept Hematol, F-76038 Rouen, France
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P455
引用
收藏
页码：S356 / S356
页数：1
相关论文
共 50 条
  • [1] Sequential chemotherapy associating Thiotepa, Etoposide and Cyclophosphamide followed by reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation for the treatment of refractory hematological malignancies
    Rubio, M. T.
    Menard, A. L.
    Malard, F.
    Mamez, A. C.
    Gomez, A.
    Brissot, E.
    Legrand, O.
    Isnard, F.
    Lapusan, S.
    Belhocine, R.
    Ruggeri, A.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S436 - S437
  • [2] Sequential conditioning with Thiotepa in T-cell replete HLA-haploidentical hematopoietic stem cell transplantation for the treatment of refractory hematological malignancies: comparison with matched related and unrelated donors
    Dulery, R.
    Menard, A-L
    Chantepie, S.
    El Cheikh, J.
    Francois, S.
    Delage, J.
    Giannotti, F.
    Ruggeri, A.
    Brissot, E.
    Battipaglia, G.
    Malard, F.
    Mamez, A-C
    Belhocine, R.
    Sestili, S.
    Vekhoff, A.
    Reman, O.
    Legrand, O.
    Rubio, M-T
    Labopin, M.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S73 - S73
  • [3] Thiotepa, Busulfan, and Fludarabine Conditioning Regimen in T Cell-Replete HLA-Haploidentical Hematopoietic Stem Cell Transplantation
    Dulery, Remy
    Bastos, Juliana
    Paviglianiti, Annalisa
    Malard, Florent
    Brissot, Eolia
    Battipaglia, Giorgia
    Mediavilla, Clemence
    Giannotti, Federica
    Banet, Anne
    Van de Wyngaert, Zoe
    Ledraa, Tounes
    Belhocine, Ramdane
    Sestili, Simona
    Adaeva, Rosa
    Lapusan, Simona
    Isnard, Francoise
    Legrand, Ollivier
    Vekhoff, Anne
    Rubio, Marie-Therese
    Ruggeri, Annalisa
    Mohty, Mohamad
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (07) : 1407 - 1415
  • [4] Related HLA-haploidentical T-cell replete peripheral stem cell transplantation with a reduced-intensity conditioning regimen to treat ANKL: a case report and literature review
    Yuan, Hailong
    Jiang, Ming
    Duan, Xianlin
    Qu, Jianhua
    Guo, Xinhong
    Liu, Ying
    Wang, Xinyou
    Xu, Jianli
    Chen, Gang
    Ding, Linglu
    Pang, Nannan
    Abulaiti, Nadiya
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (05): : 6231 - 6237
  • [5] Haploidentical Hematopoietic Stem Cell Transplantation With Reduced Intensity Conditioning, T-Cell Replete Grafts and Post-Transplant Cyclophosphamide In Pediatrics
    Seber, Adriana
    Ginani, Valeria Cortez
    Gouveia, Roseane
    Zecchin, Victor
    Barros, Daniele Porto
    Ibanez, Adriane
    Ribeiro, Leticia Alves
    Felix, Olga Margareth Wanderley Oliveira
    Diniz, Mariane Pereira
    Petrilli, Antonio Sergio
    BLOOD, 2013, 122 (21)
  • [6] Myeloablative Versus Reduced-Intensity Conditioning in HLA-Haploidentical Peripheral Blood Stem Cell Transplantation Using Posttransplant Cyclophosphamide
    Sugita, Junichi
    Kagaya, Yusuke
    Miyamoto, Toshihiro
    Shibasaki, Yasuhiko
    Nagafuji, Koji
    Ota, Shuichi
    Furukawa, Tatsuo
    Nara, Miho
    Matsuo, Keitaro
    Akashi, Koichi
    Taniguchi, Shuichi
    Harada, Mine
    Teshima, Takanori
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (03) : S58 - S58
  • [7] Sequential Regimen with Thiotepa, Cyclophosphamide, Etoposide, Fludarabine and Busulfan in Allogeneic Stem Cell Transplantation for the Treatment of Relapsed and Refractory Hematological Malignancies
    El Darsa, Haidar
    Massoud, Radwan
    Zahreddine, Ammar
    Bazarbachi, Ali
    El-Cheikh, Jean
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S390 - S391
  • [8] Sequential Regimen with Thiotepa, Cyclophosphamide, Etoposide, Fludarabine and Busulfan in Allogeneic Stem Cell Transplantation for the Treatment of Relapsed and Refractory Hematological Malignancies
    El Darsa, Haidar
    Massoud, Radwan
    Haffar, Basel
    Zaherddine, Ammar
    Bazarbachi, Ali
    Elcheikh, Jean
    BLOOD, 2017, 130
  • [9] Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide
    Junichi Sugita
    Yusuke Kagaya
    Toshihiro Miyamoto
    Yasuhiko Shibasaki
    Koji Nagafuji
    Shuichi Ota
    Tatsuo Furukawa
    Miho Nara
    Koichi Akashi
    Shuichi Taniguchi
    Mine Harada
    Keitaro Matsuo
    Takanori Teshima
    Bone Marrow Transplantation, 2019, 54 : 432 - 441
  • [10] Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide
    Sugita, Junichi
    Kagaya, Yusuke
    Miyamoto, Toshihiro
    Shibasaki, Yasuhiko
    Nagafuji, Koji
    Ota, Shuichi
    Furukawa, Tatsuo
    Nara, Miho
    Akashi, Koichi
    Taniguchi, Shuichi
    Harada, Mine
    Matsuo, Keitaro
    Teshima, Takanori
    BONE MARROW TRANSPLANTATION, 2019, 54 (03) : 432 - 441
12345